Innovator IBD Breakout Opportunities ETF

BOUT
$45.54 (- $0.21 - 0.46%)
Last updated: 2026-06-10 20:59 UTC
BOUT Metrics
Exchange
🇺🇸 NYSE ARCX
NYSE ArcaUnited StatesAmerica/New_York
SectorMid-Cap Growth
IndustryInnovator ETFs
ISINUS14016P1075
CUSIP14016P107
Market Price45.54
Dividend Yield 0.26%
Dividend Growth
1Y -46.54%
3Y +25.96%
5YN/A
10YN/A
Annual Dividend 0.25
Latest Payout ($)0.12
Latest Payout Date2026-01-02
Dividend FrequencyAnnual
P/E Ratio18.09
EPS2.07
Market CapN/A
Book ValueN/A
Price to BookN/A
Beta0.84
52w High41.63
52w Low31.08
Next Earnings DateN/A

Innovator IBD Breakout Opportunities ETF trades under ticker BOUT on NYSE as an ETF. Use this page to review its stock price, dividends, and price history. The page also shows Mid-Cap Growth exposure. Identifiers: ISIN US14016P1075, CUSIP 14016P107.

About the Company
The Innovator IBD Breakout Opportunities ETF is an exchange-traded fund that aims to provide investors with exposure to stocks that are on the verge of significant price movement, known as breakout opportunities. The fund is actively managed and tracks the IBD Breakout Stocks Index, which includes companies that exhibit strong fundamentals, growth potential, and technical characteristics indicating the likelihood of a breakout. This ETF focuses on mid- and large-cap companies, tapping into sectors that demonstrate robust growth dynamics. The Innovator IBD Breakout Opportunities ETF is notable for its strategic selection process, relying on Investor’s Business Daily’s proprietary research tools to identify promising breakout stocks. It plays a crucial role in the financial market by offering a vehicle for investors looking to capitalize on rapid growth opportunities without undertaking individual stock research. By packaging potential breakout stocks into a single investment, this ETF facilitates portfolio diversification and access to growth sectors at different market cycles. Through its targeted strategy, the Innovator IBD Breakout Opportunities ETF seeks to empower investors with potential for capital appreciation within a defined risk framework.
Price History